Monday, 13 August 2018

Amicus sets $315,000 price for new Fabry disease treatment

Amicus Therapeutics priced its new Fabry disease treatment at an average $315,000 per year in the United States, the company said on Monday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)